Table 4.

Mean, aggregate and per member per month expenditures for in vitro fertilization among commercially insured women living in a state with a comprehensive or limited mandate to cover in vitro fertilization, 2011

	Comprehensive mandatea			Limited mandateb			Ratio of PMPM expendituresd
	Adjustedc mean expenditures (SE)	Aggregate expenditures	PMPM expendi tures	Adjustedc mean expenditures (SE)	Aggregate expenditures	PMPM expenditures
Fully-insured	n = 2064			n = 256
Expenditures for infertility treatment visits	$8781 (8.5)	$18,123,899	$3.96	$9808 (9.5)	$2,510,881	$3.04	1.3
Expenditures for medication claims	$5091 (8.7)	$10,508,427	$2.29	$6801 (11.6)	$1,741,079	$2.10	1.1
Total expenditures for infertility treatment	$13,874 (14.1)	$28,635,709	$6.25	$16,508 (16.8)e	$4,225,971	$5.11	1.2
Self-insured	n = 897			n = 264
Expenditures for infertility treatment visits	$8269 (17.2)	$7,417,420	$2.27	$9205 (19.1)	$2,429,996	$2.07	1.1
Expenditures for medication claims	$5230 (7.2)	$4,691,205	$1.43	$5119 (7.0)	$1,351,302	$1.15	1.2
Total expenditures for infertility treatment	$13,480 (21.0)	$12,091,991	$3.70	$14,369 (22.3)	$3,793,490	$3.22	1.1

The total number of fully insured enrollees was 381,696 in comprehensive mandate states and 68,927 in limited mandate states. Total number of self-insured enrollees was 272,482 in comprehensive mandate states and 98,032 in limited mandate states

SE standard error, PMPM per member per month

^aComprehensive mandate states defined as those covering at least 4 IVF cycles and included Illinois, Massachusetts, New Jersey, and Rhode Island

^bLimited mandate states defined as those covering less than 4 IVF cycles and included Arkansas, Connecticut, Hawaii, and Maryland

^cAdjusted for enrollee age and region of residence

^dPMPM expenditures for women living in states with a comprehensive mandate divided by per enrollee expenditures for women living in states with a limited mandate

^eP value < .05 for comparison between comprehensive and limited mandate groups